ORKAMBI-话题@MedSci - 梅斯（MedSci）

#ORKAMBI#

5篇内容 | 953人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2029723, encodeId=0d952029e2350, content=<a href='/topic/show?id=eca4134e6aa' target=_blank style='color:#2F92EE;'>#ORKAMBI#</a>, objectTitle=囊性纤维化药物Orkambi的定价争议在英国继续存在, objectType=article, longId=161062, objectId=89251610621b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89251610621b, replyNumber=0, likeNumber=92, createdTime=2019-12-16, rootId=0, userName=12498aa2m62(暂无昵称), userId=77b32500129, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89251610621b, moduleTitle=囊性纤维化药物Orkambi的定价争议在英国继续存在, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=89251610621b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2029721, encodeId=fa482029e2129, content=<a href='/topic/show?id=eca4134e6aa' target=_blank style='color:#2F92EE;'>#ORKAMBI#</a>, objectTitle=加拿大卫生部批准ORKAMBI（lumacaftor / ivacaftor）治疗儿童囊性纤维化, objectType=article, longId=155810, objectId=8a0115581040, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a0115581040, replyNumber=0, likeNumber=68, createdTime=2019-01-04, rootId=0, userName=12498aa2m62(暂无昵称), userId=77b32500129, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a0115581040, moduleTitle=加拿大卫生部批准ORKAMBI（lumacaftor / ivacaftor）治疗儿童囊性纤维化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8a0115581040)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2029722, encodeId=dcaf2029e2224, content=<a href='/topic/show?id=eca4134e6aa' target=_blank style='color:#2F92EE;'>#ORKAMBI#</a>, objectTitle=Orkambi：欧盟批准的2-5岁儿童囊性纤维化治疗药物, objectType=article, longId=158981, objectId=4d1c1589815f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d1c1589815f, replyNumber=0, likeNumber=98, createdTime=2019-08-05, rootId=0, userName=12498aa2m62(暂无昵称), userId=77b32500129, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d1c1589815f, moduleTitle=Orkambi：欧盟批准的2-5岁儿童囊性纤维化治疗药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4d1c1589815f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2029720, encodeId=d7d22029e20c5, content=<a href='/topic/show?id=eca4134e6aa' target=_blank style='color:#2F92EE;'>#ORKAMBI#</a>, objectTitle=FDA批准Orkambi治疗6-11岁囊性纤维化患儿, objectType=article, longId=80565, objectId=82a2805651f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82a2805651f, replyNumber=0, likeNumber=67, createdTime=2017-04-16, rootId=0, userName=12498aa2m62(暂无昵称), userId=77b32500129, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82a2805651f, moduleTitle=FDA批准Orkambi治疗6-11岁囊性纤维化患儿, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=82a2805651f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2029719, encodeId=c9e62029e19fb, content=<a href='/topic/show?id=eca4134e6aa' target=_blank style='color:#2F92EE;'>#ORKAMBI#</a>, objectTitle=Vertex制药囊性纤维变性药物Orkambi遭英国NICE拒绝, objectType=article, longId=65586, objectId=93976558697, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93976558697, replyNumber=0, likeNumber=89, createdTime=2016-04-17, rootId=0, userName=12498aa2m62(暂无昵称), userId=77b32500129, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93976558697, moduleTitle=Vertex制药囊性纤维变性药物Orkambi遭英国NICE拒绝, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=93976558697)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ORKAMBI

2020-05-29

12498aa2m62(暂无昵称) (审核中...)

前往app查看评论内容

#ORKAMBI#

囊性纤维化药物Orkambi的定价争议在英国继续存在

2019-12-16

12498aa2m62(暂无昵称) (审核中...)

前往app查看评论内容

#ORKAMBI#

加拿大卫生部批准ORKAMBI（lumacaftor / ivacaftor）治疗儿童囊性纤维化

2019-01-04

12498aa2m62(暂无昵称) (审核中...)

前往app查看评论内容

#ORKAMBI#

Orkambi：欧盟批准的2-5岁儿童囊性纤维化治疗药物

2019-08-05

12498aa2m62(暂无昵称) (审核中...)

前往app查看评论内容

#ORKAMBI#

FDA批准Orkambi治疗6-11岁囊性纤维化患儿

2017-04-16

12498aa2m62(暂无昵称) (审核中...)

前往app查看评论内容

#ORKAMBI#

Vertex制药囊性纤维变性药物Orkambi遭英国NICE拒绝

2016-04-17

科室
- - 订阅+
  - 更多科室
工具
服务